一种新的SWI/SNF复合物促进三阴性乳腺癌的进展
Wen-Yi Sheng1, Yue Zhu1, Shi-Qi Liu1
1Department of Thyroid and Breast Surgery, Nanjing Medical University Affiliated Suzhou Hospital: Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, 215002, China.
Cellular & molecular biology letters
|September 1, 2025
概括
抑制ZNF382,促进三阴性乳腺癌 (TNBC) 的生长和迁移. 这一发现揭示了TNBC发展的新机制和潜在的治疗点.
科学领域:
- 癌症学
- 表观遗传学
- 分子生物学
背景情况:
- 三重阴性乳腺癌 (TNBC) 是一种致命的恶性瘤,治疗选择有限.
- SWI/SNF复合体调节染色体的可访问性和转录性.
- 辅助子单元ARID1B在染色体调节中起作用,但其在TNBC中的功能尚不清楚.
研究的目的:
- 阐明ARID1B在三阴性乳腺癌的发病过程中的作用.
- 在TNBC中识别ARID1B相互作用蛋白和下游目标基因.
- 研究ARID1B影响TNBC进展的机制.
主要方法:
- 使用免疫光和qRT- PCR分析了ARID1B的表达.
- 在体外测定和异种移植模型中评估了ARID1B的生物功能.
- 质谱,RNA-seq,双酶测定和ChIP-qPCR确定了ARID1B的相互作用和调节机制.
主要成果:
- ARID1B是TNBC的预后因子,与其已知的E3无酸酶功能相反.
- 通过与SMARCC2和SMARCB1形成新的SWI/SNF复合物,ARID1B通过转录抑制ZNF382.
- 这种复合物促进了TNBC的扩散和迁移,表明它在癌症的发展中起到了新的作用.
结论:
- 在SWI/SNF复合体内ARID1B的新功能对TNBC的进展至关重要.
- 了解SWI/SNF复合体的组合和功能,可以深入了解TNBC的致病性.
- 这些发现可能导致三阴性乳腺癌的新治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
The Nucleolus
9.1K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.1K
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K


